Literature DB >> 21454988

Vascular calcification in patients with chronic kidney disease: types, clinical impact and pathogenesis.

Pablo Román-García1, Minerva Rodríguez-García, Iván Cabezas-Rodríguez, Susana López-Ongil, Bernardino Díaz-López, Jorge B Cannata-Andía.   

Abstract

Vascular calcification plays a major role in cardiovascular disease, which is one of the main causes of mortality in chronic kidney disease patients. Vascular calcification is determined by prevalent traditional and uraemia-related (non-traditional) risk factors. It occurs mainly in the arteries, which are classified into three types according to their size and structural characteristics. In addition, vascular calcification has been associated with bone loss and fractures in chronic kidney disease patients and the general population, stressing the fact that both disorders can share pathogenetic pathways. The strategies to control vascular calcification involve several measures, chief among them the control of hyperphosphataemia. Furthermore, it has been recently described that strategies that reduce bone resorption and increase bone mineralization may decrease the risk of vascular calcifications; however, this approach still remains controversial. The mechanisms involved in vascular calcification are complex and not yet fully understood. Phosphorus plays a major role, while other factors related to bone formation have been recently identified.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21454988     DOI: 10.1159/000323434

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  8 in total

1.  Receptor activator of nuclear factor κB ligand/osteoprotegerin axis and vascular calcifications in patients with chronic kidney disease.

Authors:  Michalis Spartalis; Aikaterini Papagianni
Journal:  World J Nephrol       Date:  2016-01-06

2.  Coronary risk score for mineral bone disease in chronic non-diabetic hemodialysis patients: results from a prospective pilot study.

Authors:  Cristiana David; Jordi Bover; Cornelia Voiculet; Ileana Peride; Lucian Cristian Petcu; Andrei Niculae; Adrian Covic; Ionel Alexandru Checherita
Journal:  Int Urol Nephrol       Date:  2016-12-18       Impact factor: 2.370

Review 3.  Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.

Authors:  Jorge B Cannata-Andía; Beatriz Martín-Carro; Julia Martín-Vírgala; Javier Rodríguez-Carrio; José Joaquín Bande-Fernández; Cristina Alonso-Montes; Natalia Carrillo-López
Journal:  Calcif Tissue Int       Date:  2020-11-15       Impact factor: 4.333

4.  Arterial stiffness may be associated with mitral annular calcification based on inflammatory condition.

Authors:  Sevket Balta; Sait Demırkol; Mustafa Cakar; Omer Kurt; Mustafa Dınc
Journal:  Med Princ Pract       Date:  2013-07-26       Impact factor: 1.927

5.  Mitral annular calcification is associated with pulse wave velocity but not with augmentation index.

Authors:  Ismet Durmus; Kayıhan Karaman; Serkan Oztürk; Merih Kutlu
Journal:  Med Princ Pract       Date:  2012-10-24       Impact factor: 1.927

6.  Epicardial adipose tissue should be evaluated with other inflammatory markers in patients with subclinical hypothyroidism.

Authors:  Sevket Balta; Sait Demırkol; Ugur Kucuk; Zekeriya Arslan; Murat Unlu; Fahri Gurkan Yesil
Journal:  Med Princ Pract       Date:  2013-04-06       Impact factor: 1.927

Review 7.  Most important chronic complications of arteriovenous fistulas for hemodialysis.

Authors:  Radojica Stolic
Journal:  Med Princ Pract       Date:  2012-11-02       Impact factor: 1.927

Review 8.  Vascular Calcification-New Insights Into Its Mechanism.

Authors:  Sun Joo Lee; In-Kyu Lee; Jae-Han Jeon
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.